secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0001193125-23-240553
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex implements 1-for-15 reverse stock split effective Sept 25, 2023
------------------------------------------------------------------------

- Reverse stock split at 1-for-15 ratio, effective 5:00 p.m. ET on September 25, 2023.
- Objective to regain compliance with Nasdaq $1.00 minimum bid price by October 9, 2023.
- Stock to trade on Nasdaq under symbol VCNX on split-adjusted basis from September 26, 2023.
- Fractional shares resulting from the split will be rounded up to the nearest whole share.
- No change to authorized shares or par value; CUSIP changes to 918640202.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523240553/0001193125-23-240553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523240553/d505692d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-240553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer